Stock ABT ABBOTT LABORATORIES
Add to a list
To use this feature you must be a member
Log inSign up

News Abbott Laboratories

Equities

ABT

US0028241000

Market Closed - Nyse
Other stock markets
 04:00:02 2024-06-21 pm EDT 		5-day change 1st Jan Change
105.7 USD -0.80% Intraday chart for Abbott Laboratories +1.97% -3.95%
Jun. 20 Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health CI
Jun. 14 Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15 MT

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Abbott Laboratories : 2023 GLOBAL SUSTAINABILITY REPORT
PU
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
PR
Abbott Teams Up with the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
CI
Abbott Declares 402nd Consecutive Quarterly Dividend
AQ
Abbott Laboratories Keeps Quarterly Dividend at $0.55 Per Share, Payable on Aug.15 to Shareholders of Record on July 15
MT
Abbott Declares 402nd Consecutive Quarterly Dividend
PR
Abbott Laboratories Declares Quarterly Common Dividend, Payable on August 15, 2024
CI
Abbott Laboratories : 2023 DIVERSITY, EQUITY, AND INCLUSION REPORT
PU
Abbott Laboratories : 2023 DIVERSITY AND INCLUSION REPORT
PU
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
AQ
Abbott Laboratories Says US FDA Approved 2 Over-The-Counter Continuous Glucose Monitoring Wearable Systems
MT
US FDA clears Abbott's continuous glucose monitors for over-the-counter use
RE
Abbott Receives U.S. FDA Clearance for Two New Over-The-Counter Continuous Glucose Monitoring Systems
CI
Abbott Laboratories : Receives CE Mark for AVEIR™ DR, the World's First Dual Chamber Leadless Pacemaker System
PU
Cadrenal Therapeutics Highlights Presentation of New Trial Data at ISHLT Conference Demonstrating the Importance of Anticoagulation Quality in LVAD Patients
PR
U.S. FDA set to reorganize its food division starting October
RE
Redburn Adjusts Price Target on Abbott Laboratories to $113 From $115
MT
Medtronic beats quarterly profit estimates on medical devices strength
RE
Citigroup Adjusts Price Target on Abbott Laboratories to $119 From $128, Keeps Buy Rating
MT
Abbott Laboratories Recalling HeartMate 3 Left Ventricular Assist System Implant Kit
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABT Stock
  4. News Abbott Laboratories